Group items tagged

Overview: This webinar will provide up to date information about what constitutes blood borne pathogens from infectious materials, as well as other potentially infectious materials. The webinar will provide answers about how to prevent exposures, deal with spills or exposures should they occur, and the how to recognize the hazards of blood borne pathogens. A thorough description of the types of infections of concern for blood borne pathogens, how one might be exposed, the differences between blood born infections and other potentially infectious materials, methods for dealing with potential exposures or spills, and the requirements from OSHA to protect workers from exposure or to track exposures if they occur. Areas Covered in the Session: Infectious materials Other potentially infectious materials Prophylactic techniques that might be available Use of personal protective equipment Policies and procedures required by OSHA to protect workers Who Will Benefit: Safety Professionals Administrators Lab Workers Those who might be exposed to blood borne pathogens Speaker Profile Kenneth S. Weinberg is an independent consultant in environmental health and safety. Dr. Weinberg has consulted for several companies in the areas of OSHA Injury and Illness reporting, as well as auditing for OSHA inspections. He has worked as the Director of Safety at Mass. General Hospital in Boston for almost twelve years, and has written several books on the topics of health care safety, OSHA, and Indoor Air Quality. He has also written several articles for prominent national safety publications, and serves on the editorial advisory boards for safety publications. He Also has been Administrator of the Health Care Divisio0n of the American Society of Safety Engineers, and is a member of several panels that advice on safety related matters. Price : $139.00 Contact Info: MentorHealth Phone No: 1-800-385-1607 FaX: 302-288-6884 support@mentorhealth.com Event Link: http://bit.ly/Blood-B

Overview: This webinar will provide up to date information about what constitutes blood borne pathogens from infectious materials, as well as other potentially infectious materials. The webinar will provide answers about how to prevent exposures, deal with spills or exposures should they occur, and the how to recognize the hazards of blood borne pathogens. A thorough description of the types of infections of concern for blood borne pathogens, how one might be exposed, the differences between blood born infections and other potentially infectious materials, methods for dealing with potential exposures or spills, and the requirements from OSHA to protect workers from exposure or to track exposures if they occur. Areas Covered in the Session: Infectious materials Other potentially infectious materials Prophylactic techniques that might be available Use of personal protective equipment Policies and procedures required by OSHA to protect workers Who Will Benefit: Safety Professionals Administrators Lab Workers Those who might be exposed to blood borne pathogens Price : $139.00 Contact Info: MentorHealth Phone No: 1-800-385-1607 FaX: 302-288-6884 support@mentorhealth.com Event Link: http://www.mentorhealth.com/control/w_product/~product_id=800684LIVE/ http://www.mentorhealth.com/ LinkedIn Follow us - https://www.linkedin.com/company/mentorhealth Twitter Follow us - https://twitter.com/MentorHealth1 Facebook Like us- https://www.facebook.com/MentorHealth1

Overview: Many infectious diseases were historically confined to specific geographical regions. However, some now pose global threats due to ease of travel, globalization of trade and commerce and global warming. Government Agencies, non-Profit Organizations, Philanthropic groups and others are also funding vaccination programs for regions where infectious diseases are endemic and to deal with new outbreaks.. Such developments are stimulating research in and the development of improved vaccines, their manufacture and control. Supply Chain complexities and stability issues need to be addressed to cope with transport of vaccines to and their use in climatically hostile regions. Programs to address such challenges need to be implemented, being resourced by appropriately trained and qualified staff from a number of disciplines. Development programs for immuno oncology products also require staffing by similarly skilled professionals. Workers currently engaged in Discovery, Development and Manufacture of conventional medications , or those seeking career-change opportunities can develop an understanding of the concepts, constraints and opportunities associated with Vaccine products by attendance at the Webinar. Engineering professionals involved in facility construction, or repurposing can also benefit as can Regulatory Affairs Professionals or staff at medicines Evaluation Agencies. The subject matter is particularly suited to professionals who are expert in the various disciplines associated with conventional medications ("so-called "small molecules") who wish to expand and develop their skills by involvement in vaccine-related programs including immuno-oncology. Areas Covered in the Session: History of and development of vaccine concepts. undamentals of vaccination Vaccine Types Administration of Vaccines Future Concepts Immuno-Oncology Vaccine Manufacture Who Will Benefit: Regulatory Affair Managers Project Management Personnel QA Managers Scientists Technol

Approximately 2 billion people suffer from Tuberculosis each year. Tuberculosis or simply TB is an infectious and highly contagious disease of the body especially lungs. It spreads mainly via Mycobacterium tuberculosis which is a tough and highly resistant microbe.

Tuberculosis is a serious, infectious and often fatal disease of the lungs. It can also affect other parts of the body. But the most common type of Tuberculosis is pulmonary Tuberculosis. It is more common in women than in men. The causative agent is a Gram-positive bacterium (Mycobacterium tuberculosis).

Course "HIPAA for the Compliance Officer" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: I will be going into great detail regarding you practice or business and how it relates to the HIPAA Security/Privacy Rule, Areas covered will be history of HIPAA, privacy vs security, business associates, changes for 2016, audit process, paper based PHI, HIPAA and suing, texting, email, encryption, medical messaging, voice data and much, much, more I will uncover myths versus reality as it relates to this very enigmatic law based on over 600 risk assessments performed as well as years of experience in dealing directly with the Office of Civil Rights HIPAA auditors. I will also speak to real life audits conducted by the Federal government (I've been on both sides of these audits) what your highest risks are for being fined (some of the risk factors may surprise you). In addition, this course will cover the highest risk factors for being sued for wrongful disclosures of PHI and the manner in which patients are now using state laws to sue for wrongful disclosures. Don't always believe what you read online about HIPAA, especially as it relates to encryption and IT, there are a lot of groups selling more than is necessarily required. Why you should attend: This lesson will be addressing how practice/business managers (or compliance offers) need to get their HIPAA house in order before the imminent audits occur. It will also address major changes under the Omnibus Rule and any other applicable updates for 2016. There are an enormous amount of issues and risks for covered entities and business associates these days. I will speak on specific experiences from over 17 years of experience in working as an outsourced compliance auditor, expert witness on HIPAA cases, and thoroughly explain how patients are now able to get cash remedies for wrongful disclosures of private health information. More im

Course "New HIPAA Audit and Enforcement Activities: Being Prepared to Show your Compliance " has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: We will be discussing the history and evolution of HIPAA Privacy/Security and the major points you need to understand to proactively protect your practice or business from the imminent federal auditing process: * History of HIPAA * HITECH * HIPAA Omnibus Rule * How to perform a HIPAA Security Risk Assessment * What is involved in a Federal audit and how is it conducted * Risk factors for a federal audit * How to avoid a Federal audit * Business Associates and HIPAA audits * EHR and HIPAA * Business Continuity/Disaster Recovery Planning * Assessing your contractors and sub-contractors * In depth discussions on IT down to the nuts and bolts * Risk factors that can cause an audit (low hanging fruit) * New rules which grant states ability to sue citing HIPAA on behalf of a patient * New funding measures Why should you attend : The evolutions of this enigmatic law and how what was once relative benign in terms of enforcement is now fully funded and aggressive. Learn what you can do to be prepared for an audit and how to lower risks of ever being audited. It is absolutely imperative that you are proactive and not reactive with your compliance program, this is a necessary evil and you need to protect your practice or your business and limit risks from the imminent Federal audits. Join me in keeping up with this very confusing law and take advantage of all the templates and information provided as part of the seminar. Areas Covered in the Session: * HIPAA -Brief History * HIPAA Privacy Rule vs HIPAA Security Rule * HITECH Act * Breach Notification Rule * Omnibus Rule and audits * Business Associates and audits * Current Court Cases (precedence) * Paper Based PHI Concerns and how to lower risk

Several factors contribute to hearing loss in adults such as genetics, level of noise exposure, age, trauma and infectious diseases such as meningitis.

Apollo Hospitals Mumbai which treats other medical specialities like Infectious Diseasses, Pulmonology, ENT, Dental, Diabetology & Endocrinology and more.

Contract manufacturing is a complex process involved in producing vaccine products. This type of production usually involves the manufacturing of vaccines in a single step. Contract manufacturers usually produce vaccines at their facilities; however, some contract manufacturers also service the field through the provision of workspace and by taking care of the closing storage and final disposition of finished products. Some contract manufacturers specialize in the manufacture of one or few vaccines. Others manufacture vaccines for a number of diseases. Technological developments in biomanufacturing and biotechnology are expected to drive growth of the global vaccine contract manufacturing market. Biotechnology has witnessed significant growth in the recent past in both developed and emerging economies. According to the India Brand Equity Foundation (IBEF), the Indian biotechnology industry was valued at US$ 63 billion in 2019 and is expected to reach US$ 102 billion by 2025, registering a CAGR of 10.9%. Besides, key biotechnology and pharmaceutical companies are focused on launching vaccines for protection against infectious diseases. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/03/vaccine-contract-manufacturing-market.html

Peyronie's disease (Pdy) is a sexually transmitted disease caused by the infectious agent of the same name - the bacteria known as folliculitis. Peyronie's disease is more common in men than in women, with approximately 3% of men being affected by it. This disease is most commonly associated with poor oral hygiene, although sexual intercourse can also cause it. The precise causes of this condition are not known, but heredity, diabetes, and injury to the urethra may all be contributing factors. The primary treatment of Peyronies is the surgical removal of the papillae, which are found on the tip of the penis. Peyronie's disease (Pdy) is clinically classified as an intervertebral disk disease and is often difficult to diagnose. The growing prevalence of Peyronie's disease around the globe is propelling the growth of the Peyronie's disease treatment market. According to the American Academy of Family Physicians, it primarily affects men between 45 and 60 years of age, although an age range of 18 to 80 years. This disease occurs more often in men between 40 to 70 years older. Improved healthcare facilities across developing regions coupled with the availability of the multiple treatment options due to advancement in technology are again propelling the market growth. Moreover, the increasing geriatric population around the globe is further projected to foster the growth of Peyronie's disease treatment market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/increasing-incidence-of-sexually.html

Immunoassays, or DNA assays, are a method of DNA analysis. DNA is the basis of all biological material, including the DNA of living organisms, cells, and tissues. This method can be used to analyze, identify, and profile various biological samples. The analysis of DNA has developed greatly over the years, due to the ability to conduct DNA tests on living people. The use of immunoassays for gene-based analysis has grown tremendously. Primarily, immunoassay analysis is used to evaluate gene-based treatments in oncology, cardiovascular, orthopedics, infectious diseases, and clinical diagnostics. Currently, the primary uses of immunoassays are for the evaluation of gene-based therapies in oncology and cardiovascular clinical trials. The analysis and measurement of immune parameters by immunoassay instruments are known as response curve analysis (RCA). The first analysis of RCA was done by Ward and coworkers in 1980, using monoclonal antibodies to stimulate the lymphocytes Subsequent immunoassay measurement models and systems have been developed to extend the scope of research and to make immunoassay measurement more cost-effective. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/immunoassay-instrument-is-gaining-rapid.html

Forensic pathology is the application of clinical medical jurisprudence in forensic medicine. A forensic pathology specialist is a physician who has completed a residency in molecular biology, pathology, and related disciplines and has then specialized in forensic pathology as a post-graduate program. The standards for being a "fully certified" forensic pathology specialist vary from state to state. There are also national accreditation programs that offer associates or bachelor's degrees for forensic pathology specialists. Forensic pathology can be applied to a wide range of situations, such as drug and alcohol abuse, homicide and other crimes, sexual assault, and sexual motivation. Forensic pathology specialists can analyze tissue samples to examine for disease, and they use various methods to determine the cause of death, cause of trauma, etc. For instance, gas chromatography is used in the forensic pathology for analyzing fibers on the body. Moreover it also used to analyze blood found at a crime scene. There are many types of forensic pathology, and each type involves different techniques and terminology. Some examples include: pathology of blood and other bodily fluids; pathology of sexually transmitted diseases; pathology of trauma; pathology of forensic genitourinary and obstetric disorders; pathology of traumatic and infectious diseases; pathology of unidentified remains. Read More @ https://www.blogger.com/blog/post/edit/preview/9197580861156902959/6381348933167984177

A biologic drug (biologics) is a product that is produced from living organisms or contains components of living organisms. Biologic drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Biologics drugs are derived from a wide variety of natural sources such as human, animal, or microorganisms by using biotechnology. Moreover, Biologics include a wide variety of products such as blood and blood components, vaccines, tissues, allergenic, gene therapy, somatic cells, and recombinant therapeutic proteins. Novel therapies and new technologies are emerging to create new biologics, which holds a prominent future for the biologics market. The market is majorly driven by the increasing prevalence of chronic diseases across the globe, growing capital investment by key players, and higher acceptability and increasing demand for innovative therapies. For instance, according to the National Health Council, around 157 million Americans are expected to have more than one chronic disorder by 2020. Moreover, according to the World Health Organization, diabetes, cancer, and cardiovascular diseases account for around 1.6 million, 9 million, and 17.9 million deaths each year, respectively. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/11/increasing-prevalence-of-chronic.html

An N95 mask is a commonly-used, shortened name for N95 respirators, which is actually a particulate-filter respirator that meting the U.S. national institute for Occupational Safety and Health (NIOSH) standards. Respirators are designed to protect you from inhaling harmful dust particles and fumes. But when it comes to choosing a respirator for use in the home or on the job, there are certain features you need to look for. The first and most important feature to look for is that it is safe for you to wear. Respirators are generally divided into two types. The first is the full-face respirator, while the other type is the full-body respirators. While there are some differences between these two types of respirators, both have the same main functions. High prevalence of infectious diseases is expected to propel growth of the global N95 grade medical protective masks market over the forecast period. For instance, according to the World Health Organization, in 2018, India reported around 2.69 million cases of tuberculosis. Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global N95 grade medical protective masks market. For instance, globally, as of 3:33pm CET, 17 November 2020, there have been 54,771,888 confirmed cases of COVID-19, including 1,324,249 deaths, reported to the World Health Organization. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/11/emergence-of-covid-19-to-augment-growth.html

The term "porcine vaccines" refers to the vaccines developed and used in animals, rather than in humans. The purpose of porcine vaccines is to protect farm animals from things like bacterial and viral diseases. The problem is that a lot of the viruses and bacteria that affect humans aren't infectious to animals, so it's difficult to develop vaccines against them. The two major types of porcine vaccines are Bovine Adverse Genomeopathy (BAG) and Meningitis. The former vaccine is more commonly known as the Meningitis vaccination; the latter is the Bago vaccine. Both vaccines prevent harmful viruses in the animals' bloodstream. However, they do have a few differences in how they work Increasing demand for pork worldwide is expected to drive growth of the global porcine vaccines market. According to the Organisation for Economic Co-operation and Development (OECD), the total pork consumption in OECD countries reached 23.0 kilogram/capita in 2019, increasing from 22.1 kilograms/capita in 2010. The rise in pork consumption is attributed to the rapidly growing population and rising disposable incomes in emerging economies. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/porcine-vaccines-market-is-growing.html

Abbott laboratories received the U.S. Food and Drug Administration (FDA) for its next-generation Influenza A & B2 and Strep A2 molecular assays. These assays are used for the molecular detection and differentiation of influenza A and B virus. Next-generation Influenza A & B2 and Strep A2 molecular assays are currently available on ID NOW platform, which is a rapid isothermal system. It is used for the detection of infectious diseases such as influenza.

This market experienced growth in 2017 owing to surge in the use of pathological examination tests attributed to the increase in prevalence of several infectious diseases across the globe. Furthermore, surge in geriatric population and rise in health awareness are expected to foster the market growth. However, lack of reimbursement policies and decline skilled and trained healthcare professionals is anticipated to restrain the market growth during the forecast period.

Molecular diagnosis is a method used to identify a disease at the molecular level, such as proteins, DNA, and RNA, in a tissue or fluid. Various tools are used to detect specific sequences of DNA or RNA that may or may not be associated with the disease such as single nucleotide polymorphism (SNP), deletions, rearrangements, and insertions, which are used for diagnosis and prediction of various infectious diseases, cancer, and other genetic disorders.